Abstract

Formation of the lymphatic system requires the coordinated expression of several key regulators: vascular endothelial growth factor C (VEGFC), its receptor FLT4, and a key transcriptional effector, PROX1. Yet, how expression of these signaling components is regulated remains poorly understood. Here, using a combination of genetic and molecular approaches, we identify the transcription factor hematopoietically expressed homeobox (HHEX) as an upstream regulator of VEGFC, FLT4, and PROX1 during angiogenic sprouting and lymphatic formation in vertebrates. By analyzing zebrafish mutants, we found that hhex is necessary for sprouting angiogenesis from the posterior cardinal vein, a process required for lymphangiogenesis. Furthermore, studies of mammalian HHEX using tissue-specific genetic deletions in mouse and knockdowns in cultured human endothelial cells reveal its highly conserved function during vascular and lymphatic development. Our findings that HHEX is essential for the regulation of the VEGFC/FLT4/PROX1 axis provide insights into the molecular regulation of lymphangiogenesis.

Details

Title
HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development
Author
Gauvrit, Sébastien 1   VIAFID ORCID Logo  ; Villasenor, Alethia 1 ; Strilic, Boris 2 ; Kitchen, Philip 3 ; Collins, Michelle M 1 ; Marín-Juez, Rubén 1 ; Guenther, Stefan 4 ; Hans-Martin Maischein 1 ; Fukuda, Nana 1 ; Canham, Maurice A 5 ; Brickman, Joshua M 6 ; Bogue, Clifford W 7   VIAFID ORCID Logo  ; Jayaraman, Padma-Sheela 3 ; Stainier, Didier Y R 1   VIAFID ORCID Logo 

 Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany 
 Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany 
 Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK 
 ECCPS Bioinformatics and Deep Sequencing Platform, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany 
 School of Biological Sciences, Institute for Stem Cell Research, MRC Centre for Regenerative Medicine, Edinburgh, UK 
 Novo Nordisk Foundation Centre for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark 
 Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA 
Pages
1-14
Publication year
2018
Publication date
Jul 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2069382953
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.